Fisher update: We received last week's bone marrow test results earlier this week. Unfortunately, he still has cancer. There is one available treatment option which is a new clinical trial that recently opened up at St Jude and he will be the very first person to do this if he is stable enough. It consists of Chris donating his T cell and after a process, his cells will be infused into Fisher.

Meanwhile, our medical team will need to keep fishers' disease level at bay. He will have low-dose chemo in Macon while we wait on the trial process at St Jude. Chris will have appointments in Memphis tomorrow and next Friday he will have a full day of cell collection. Fisher will be going on May 13 to St Jude and the plans are to have cells infused on May 28 we will have to stay in Memphis for one month. For now, this is the plan. Fisher is unsure about this as we all are but he wants to continue the fight.

Trial Information: MEMCAR19 

A PHASE I STUDY EVALUATING ALLOGENEIC MEMORY T CELLS ENGINEERED TO EXPRESS CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR CD19 FOR THE TREATMENT OF PEDIATRIC AND YOUNG ADULT PATIENTS ≤ 21 YEARS OF AGE WITH RELAPSED OR REFRACTORY CD19-POSITIVE ACUTE LYMPHOBLASTIC